Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
Clinical trial NCT05111067 · COMPLETED
Trial details
- NCT number
- NCT05111067
- Sponsor
- Nova Scotia Health Authority
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.